Bio-Linked™ participants have the opportunity to advance cancer treatment research by donating mononuclear cells. Cellerant Therapeutics, a clinical-stage California-based company, is developing cell- and antibody-based drugs that can aid in stem cell transplant recovery.
Bio-Linked™ is seeking adults eligible for whole blood donation who weigh at least 110 pounds for Cellerant's trials. Participants are eligible for compensation up to $1,000. Mononuclear cells are separated and extracted from whole blood during apheresis blood donation, a process that takes approximately 120 minutes. The cells will help Cellerant produce drugs that lessen the chance of infection and aid in recovery for transplant recipients.
In order to be eligible to participate, donors must fully complete their BioProfile on the Bio-Linked website. They must also accept research opportunities on their BioProfile. Under preferences, be sure to note your preferred method of contact, and mark “Donate Apheresis White Blood Cells” on the slide for donation types you are willing to offer. Bio-Linked™ will use the information in completed profiles to determine if a potential participant meets the requirements for the research study. Bio-Linked™ will contact you with potential research opportunities.
Through Bio-Linked™ and Bio-Sharing™, participating blood centers provide the blood cells necessary to support Cellerant Therapeutics' breakthrough stem cell-based immunology studies that could lead to new cancer treatments and cures.
Read more news from Bio-Linked™
Subscribe to our quarterly newsletter